AMGN - CIK 0000318154
AMGEN INC (AMGN) reported revenue of $33.42B for fiscal year 2024, up 18.6% from $28.19B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | revenue |
|---|---|---|
| Q1 | 2024-03-31 | $7.45B |
| Q2 | 2024-06-30 | $8.39B |
| Q3 | 2024-09-30 | $8.50B |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
AMGEN INC (AMGN) reported revenue of $33.42B for fiscal year 2024, up 18.6% from $28.19B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
In the following fiscal year (2025), AMGEN INC reported revenue of $36.75B, an increase from the $33.42B reported in fiscal 2024.
See the full AMGN revenue history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.